You just read:

Daiichi Sankyo's VANFLYTA® Receives Approval in Japan for the Treatment of Relapsed/Refractory FLT3-ITD AML

News provided by

Daiichi Sankyo Company, Limited

Jun 18, 2019, 08:00 ET